CYP19A1 and medical procedure: A novel IFNAR1 transcript detected in the ‘late/none-recurrent’ group has an alternative 3’ accept site; the canonical IFN \documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$\mathrm{\alpha }$$\end{document}α signaling pathway is involved in metastasis26 and aromatase inhibitor resistance in breast cancer27.